-Issues related to FDA review of active ingredients in over-the-counter products
2025 · 3rd Quarter (July 1 - Sep 30)
THE PROCTER AND GAMBLE COMPANY
Filed by THE PROCTER AND GAMBLE COMPANY.
Open official filingSource-reported fields
Filing overview
- Type
- 3rd Quarter - Report
- Posted
- Oct 22, 2025
- Income
- Not reported
- Expenses
- $751,000.00
- Registrant
- THE PROCTER AND GAMBLE COMPANY
- Filing UUID
- 6b1fed12-8c8c-46d6-bb5c-26b1f7b55ad4
- Termination date
- Not reported
Expense method: C
Literal source text
Lobbying issues and bill citations
-H.R.4273: Over-the-Counter Monograph Drug User Fee Amendments (Entire Bill)
Literal federal measure citations: H.R.4273
-Issues related to Toxic Substances Control Act reform (No Bill)
-Issues related to plastics recycling (No Bill)
-OECD Digital Tax Project (Global Minimum Tax Implementation) -Implementation of H.R. 1 (One Big Beautiful Bill - Corporate/International Tax Provisions) -S.2003 (Strengthening Benefit Plans Act of 2025) -H.R. 1 (One Big Beautiful Bill Act - Corporate/International Tax Provisions)
-Issues related to IEEPA Reciprocal Tariffs -Issues related to Softwood Lumber 232 Trade Investigation -Issues related to America First Trade Policy -Issues related to tariffs (232 Pharmaceuticals)
-Issues Related to Gross Vehicle Weight Limits (no bill)
-Issues related to Asia-Pacific Economic Cooperation (APEC) -Issues related to Middle East (Syria US export controls) -Issues related to Latin America
-Issues related to product safety
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.